The WHO Mental Health Gap Action Programme for mental, neurological, and substance use conditions: the new and updated guideline recommendations
Elaine Brohan,Neerja Chowdhary,Tarun Dua,Corrado Barbui,Graham Thornicroft,Dévora Kestel,WHO mhGAP guideline team. Electronic address: mhgap-info@who.int,WHO mhGAP guideline team,Amza Ali,Sawitri Assanangkornchai,Henry Brodaty,Vladimir Carli,Rabih El Chammay,Odille Chang,Pamela Y Collins,Pim Cuijpers,Christopher Dowrick,Julian Eaton,Cleusa P Ferri,Sandra Fortes,Michael P Hengartner,Asma Humayun,Nathalie Jette,Petrus J de Vries,Maria Elena Medina-Mora,Pratima Murthy,Dinah Nadera,Charles Newton,Michael Njenga,Olayinka Omigbodun,Afarin Rahimi-Movaghar,Atif Rahman,Palmira Fortunato Dos Santos,Shekhar Saxena,Lakshmi Vijayakumar,Huali Wang,Pichayanan Wattanavitukul,Enat Yewnetu,Ken Carswell,Sudipto Chatterjee,Batool Fatima,Alexandra Fleischmann,Brandon Gray,Charlotte Hanlon,Fahmy Hanna,Dzmitry Krupchanka,Aiysha Malik,Mark van Ommeren,Vladimir Poznyak,Katrin Seeher,Chiara Servili,Inka Weissbecker,Florence Baingana,Luis Alfonzo Bello,Andrea Bruni,Ana Carina Jorge Dos Santos Ferreira Borges Bigot,Chencho Dorji,Martin Vandendyck,Ledia Lazeri,Maristela Goldnadel Monteiro,Manju Rani,Khalid Saeed,Renato Oliveira E Souza,Wole Ameyan,Valentina Baltag,Francesco Branca,Bernadette Cappello,Giorgio Cometto,Suraya Dalil,Albis Gabrielli,Benedikt Huttner,Ernesto Jaramillo,Taskeen Khan,Jonathan King,Ruediger Krech,Nathalie Roebbel,Nhan Tran,Yuka Sumi
DOI: https://doi.org/10.1016/S2215-0366(23)00370-X
Abstract:The WHO Mental Health Gap Action Programme (mhGAP) guideline update reflects 15 years of investment in reducing the treatment gap and scaling up care for people with mental, neurological, and substance use (MNS) conditions. It was produced by a guideline development group and steering group, with support from topic experts, using quantitative and qualitative evidence and a systematic review of use of mhGAP. 90 recommendations from the 2015 guideline update were validated and endorsed for use in their current format. These are joined by 30 revised recommendations and 18 new recommendations, including a new module on anxiety. Psychological interventions are emphasised as treatments and digitally delivered interventions feature across many modules, as well as updated recommendations for psychotropic medicines. Research gaps identified include the need for evidence from low-resource settings and on the views of people with lived experience of MNS conditions. The revised recommendations ensure that mhGAP continues to offer high-quality, timely, transparent, and evidence-based guidance to support non-specialist health workers in low-income and middle-income countries in providing care to individuals with MNS conditions.